Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now X
ETFs with PCRX as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|4.18%||ALPS Medical Breakthroughs ETF (SBIO)||N/A (N/A)|
|3.57%||SPDR S&P Pharmaceuticals ETF (XPH)||+18.78 (17.68%)|
|1.17%||Guggenheim Insider ETF (NFO)||+3.50 (7.53%)|
|0.84%||iShares Morningstar Small-Cap Growth ETF (JKK)||+16.98 (13.58%)|
Company Description (as filed with the SEC)
Pacira Pharmaceuticals, Inc. is the holding company for our California operating subsidiary, or Pacira California. In March 2007, we acquired Pacira California from SkyePharma Holdings, Inc., or Skyepharma (referred to in this Annual Report on Form 10-K as the "Acquisition"). Unless the context requires otherwise, references to "Pacira," "we," the "company," "us" and "our" in this Annual Report on Form 10-K refers to Pacira Pharmaceuticals, Inc. and its subsidiaries. In addition, references in this Annual Report on Form 10-K to DepoCyt(e) mean DepoCyt when discussed in the context of the United States and Canada and DepoCyte when discussed in the context of Europe. Corporate Information We were incorporated in Delaware under the name Blue Acquisition Corp. in December 2006 and changed our name to Pacira, Inc. in June 2007. In October 2010, we changed our name to Pacira Pharmaceuticals, Inc. ... More ...
Where does PCRX fit in the risk graph?
|Annual EPS Est:||$-0.28|
|Quarterly EPS Est:||0.06|